Product Identifiers
Catalog # | NX25842 |
CAS Number | 152459-95-5 |
PubChem CID | 5291 |
Chemical Name | Imatinib |
IUPAC Name | 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide |
Synonym | CGP-57148B, STI-571 |
InChI | InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34) |
InChIKey | KTUFNOKKBVMGRW-UHFFFAOYSA-N |
SMILES | CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1 |
MDL Number | MFCD05662257 |
Specification
MW | 493.6 |
MF | C29H31N7O |
Assay | >99% |
Product Notes | Free Base, >99%. Imatinib is the active ingredient in the drug sold under the trade name Gleevec¨ in USA or Glivec in Europe and Australia |
Special Remarks | Store at -20¡C |
Cat Number | BIFK0025 |
Manufacturer | Apollo Scientific |
Country of Origin | United Kingdom |